Canton Strategic Holdings, Inc.

AI-generated fair value estimate for this company.

Method: Digital-asset treasury NAV: Total assets of $584.7M (Q1 2026, dominated by $541.6M of Canton Coin token holdings plus $41.5M cash) minus the $113.7M deferred tax liability tied to those unrealized token gains = $471.0M net asset value, divided by ~37.1M shares outstanding.

Reasoning: Canton Strategic Holdings (formerly a biopharma, now a Canton Network 'Super Validator') reports zero revenue since inception and its entire value is a direct claim on its crypto-token treasury, so a NAV-of-holdings approach (as used for closed-end funds/digital-asset treasury vehicles) is far more grounded than a cash-flow DCF for a business with no operating cash flows; this NAV sits above the current market price, consistent with the market discounting token-price volatility, liquidity, and execution risk that this balance-sheet-based estimate does not capture.